Cori Campbell

Assistant Professor

University Medical Center Groningen

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Cori Campbell is an Assistant Professor at the University Medical Center Utrecht, Netherlands. Her research focuses on hepatitis B virus (HBV) epidemiology, the impact of socio-economic factors on health outcomes, and the effects of the COVID-19 pandemic on chronic disease management. Dr. Campbell has published extensively on topics including primary liver cancer, data reuse from clinical trials, and the validation of risk prediction models for early detection in primary care populations.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (11)

Dr Jolynne Mokaya

Wellcome Sanger Institute

UNITED KINGDOM

View details

Weiqi Liao

University of Oxford

UNITED KINGDOM

View details

Tingyan (Tina) Wang

University of Oxford

UNITED KINGDOM

View details

Philippa Matthews

University College London Hospitals NHS Foundation Trust

UNITED KINGDOM

View details

Anna McNaughton

University of Bristol

UNITED KINGDOM

View details

Peter Jepsen

Aarhus University

DENMARK

View details

Anthony Brown

University of Oxford

UNITED KINGDOM

View details

Eleanor Barnes

Professor of Hepatology and Experimental Medicine

University of Oxford

UNITED KINGDOM

View details

Murali Kesavan

University of Oxford

UNITED KINGDOM

View details

Ali Amini

University of Oxford

UNITED KINGDOM

View details

Steve Harris

University of Oxford

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Cori Campbell

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Analysis of primary care electronic health record data of people living with hepatitis B virus: infection and hepatocellular carcinoma risk associated with socio-economic deprivation

Disparities in care and outcomes for primary liver cancer in England during 2008–2018

Estimating the epidemiology of chronic Hepatitis B Virus (HBV) infection in the UK: what do we know and what are we missing?

A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: Data to inform clinical care and health policy

Impact of the COVID-19 pandemic on routine surveillance for adults with chronic hepatitis B virus (HBV) infection in the UK

Where do those data go? Reuse of screening results from clinical trials to estimate population prevalence of HBV infection in adults in Kilifi, Kenya

Development and validation of personalised risk prediction models for early detection and diagnosis of primary liver cancer among the English primary care population using the QResearch® database: research protocol and statistical analysis plan

Impaired humoral and cellular response to primary COVID-19 vaccination in patients less than 2 years after allogeneic bone marrow transplant.

Longitudinal Analysis of the Utility of Liver Biochemistry as Prognostic Markers in Hospitalized Patients With Corona Virus Disease 2019

Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated

Collaborators (11)

Dr Jolynne Mokaya

Weiqi Liao

Tingyan (Tina) Wang

Philippa Matthews

Anna McNaughton

Peter Jepsen

Anthony Brown

Eleanor Barnes

Murali Kesavan

Ali Amini

Steve Harris

Make your next move.